Visions & reflections (Minireview) phosphoinositides and charcot-marie-tooth disease: New keys to old questions

Cellular and Molecular Life Sciences

Volumn 64, Issue 24, 2007, Pages 3261-3265

  Suter, U ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Charcot Marie Tooth disease; Genetic basis; Hypotheses; Mechanisms; Phosphoinositides

Indexed keywords

PHOSPHATIDYLINOSITOL;

BIOLOGICAL MODEL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; PHYSIOLOGY; REVIEW;

CHARCOT-MARIE-TOOTH DISEASE; HUMANS; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOLS;

EID: 39749130486     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-007-7381-7     Document Type: Review

References (29)

1. Suter, U. and Scherer, S. S. (2003) Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4, 714-726.
2. Niemann, A., Berger, P. and Suter, U. (2006) Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.Neuromol. Med. 8, 217-242.
3. Berger, P., Niemann, A. and Suter, U. (2006) Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia 54, 243-257.
4. Nave, K. A., Sereda, M. W. and Ehrenreich, H. (2007) Mechanisms of disease: Inherited demyelinating neuropathies - From basic to clinical research. Nat. Clin. Pract. Neurol. 3, 453-464.
5. Di Paolo, G. and De Camilli, P. (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657.
6. Nave, K. A. and Salzer, J. L. (2006) Axonal regulation of myelination by neuregulin 1. Curr.Opin. Neurobiol. 16, 492-500.
7. Schafer, D. P. and Rasband, M.N. (2006) Glial regulation of the axonal membrane at nodes of Ranvier. Curr. Opin. Neurobiol. 16, 508-514.
8. Roth, M. G. (2004) Phosphoinositides in constitutive membrane traffic. Physiol. Rev. 84, 699-730.
9. Robinson, F. L. and Dixon, J. E. (2006) Myotubularin phosphatases: Policing 3-phosphoinositides. Trends Cell Biol. 16, 403-412.
10. Bolis, A., Zordan, P., Coviello, S. and Bolino, A. (2007) Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system.Mol. Neurobiol. 35, 308-316.
11. Tersar, K., Boentert, M., Berger, P., Bonneick, S., Wessig, C., Toyka, K. V., Young, P. and Suter, U. (2007) Mtmr13/Sbf2- deficient mice: An animal model for CMT4B2. Hum. Mol. Genet. (in press).
12. Berger, P., Berger, I., Schaffitzel, C., Tersar, K., Volkmer, B. and Suter, U. (2006) Multi-level regulation of myotubularinrelated protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. Hum. Mol. Genet. 15, 569-579.
13. Berger, P., Bonneick, S., Willi, S., Wymann, M. and Suter, U. (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet. 11, 1569-1579.
14. Bolino, A., Bolis, A., Previtali, S.C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D. D., Feltri, M. L., Cheng, C. Y., Quattrini, A. and Wrabetz, L. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell Biol. 167, 711-721.
15. Bonneick, S., Boentert, M., Berger, P., Atanasoski, S., Mantei, N., Wessig, C., Toyka, K. V., Young, P. and Suter, U. (2005) An animal model for Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet. 14, 3685-3695.
16. Bolis, A., Coviello, S., Bussini, S., Dina, G., Pardini, C., Previtali, S. C., Malaguti, M., Morana, P., Del Carro, U., Feltri, M. L., Quattrini, A., Wrabetz, L. and Bolino, A. (2005) Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings. J. Neurosci. 25, 8567-8577.
17. Fili, N., Calleja, V., Woscholski, R., Parker, P. J. and Larijani, B. (2006) Compartmental signal modulation: Endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting. Proc. Natl. Acad. Sci. USA 103, 15473-15478.
18. Chow, C. Y., Zhang, Y., Dowling, J. J., Jin, N., Adamska, M., Shiga, K., Szigeti, K., Shy, M.E., Li, J., Zhang, X., Lupski, J. R., Weisman, L. S. and Meisler, M. H. (2007) Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448, 68 -72.
19. Volpicelli-Daley, L. and De Camilli, P. (2007) Phosphoinositides link to neurodegeneration. Nat. Med. 13, 784-786.
20. Sbrissa, D., Ikonomov, O. C., Fu, Z., Ijuin, T., Gruenberg, J., Takenawa, T. and Shisheva, A. (2007) Core protein machinery for mammalian phosphatidylinositol 3, 5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport: Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J. Biol. Chem. 282, 23878-23891.
21. Stendel, C., Roos, A., Deconinck, T., Pereira, J., Castagner, F., Niemann, A., Kirschner, J., Korinthenberg, R., Ketelsen, U. P., Battaloglu, E., Parman, Y., Nicholson, G. et al. (2007) Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am. J. Hum Genet. 81, 158-164.
22. Delague, V., Jacquier, A., Hamadouche, T., Poitelon, Y., Baudot, C., Boccaccio, I., Chouery, E., Chaouch, M., Kassouri, N., Jabbour, R., Grid, D., Megarbane, A. et al. (2007) Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie- Tooth type 4H. Am. J. Hum. Genet. 81, 1-16.
23. Zuchner, S., Noureddine, M., Kennerson, M., Verhoeven, K., Claeys, K., De Jonghe, P., Merory, J., Oliveira, S. A., Speer, M. C., Stenger, J. E., Walizada, G., Zhu, D. et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet. 37, 289-294.
24. McNiven, M. A. (2005) Dynamin in disease. Nat. Genet. 37, 215-216.
25. von Zastrow, M. and Sorkin, A. (2007) Signaling on the endocytic pathway. Curr. Opin. Cell Biol. 19, 436-445.
26. Balla, T. (2007) Imaging and manipulating phosphoinositides in living cells. J. Physiol. 582, 927-937.
27. Zuchner, S. and Vance, J. M. (2006) Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies. Nat. Clin. Pract. Neurol. 2, 45-53.
28. Fortun, J., Go, J. C., Li, J., Amici, S. A., Dunn, W. A. Jr. and Notterpek, L. (2006) Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol. Dis. 22, 153-164.
29. Naef, R. and Suter, U. (1998) Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc. Res. Tech 41, 359-371.